---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-063627"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2024-07-23T23:59:59+00:00"
generated_at: "2026-05-31T17:49:17.414485+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma CFO suspends work amid salary dispute; company corrects license fee numbers downward

## Summary
- CFO Leeds Chow suspends work due to disagreements over salary owed; CEO Uttam Patil becomes interim CFO.
- Potential aggregate license fee corrected from $24M to $19M in prior press release.
- Total possible cash payment from licensees corrected from $23.7M to $18.7M.
- Disagreement limited to salary; not related to public filings disclosures.

## SEC filing metadata
- accession: 0001213900-24-063627
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2024-07-23T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390024063627/0001213900-24-063627-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390024063627/ea020990501-8k_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-063627
- JSON: https://secwatch.observer/filing/0001213900-24-063627.json
- Plain text: https://secwatch.observer/filing/0001213900-24-063627.txt

## Key facts
- Executive change
  Leeds Chow departed as Chief Financial Officer at ABVC BIOPHARMA, INC..
  - Action: suspending his work
  - Role: Chief Financial Officer
  source text: due to disagreements regarding salaries due and payable, Mr. Chow has informed the Company that he is suspending his work as CFO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173313/000121390024063627/0001213900-24-063627-index.htm
- Executive change
  Uttam Patil was appointed as interim Chief Financial Officer at ABVC BIOPHARMA, INC..
  - Action: assume the duties of interim Chief Financial Officer
  - Role: interim Chief Financial Officer
  source text: The Company’s CEO, Uttam Patil, will assume the duties of interim Chief Financial Officer until the parties settle the disagreement and Leeds resumes his position as CFO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173313/000121390024063627/0001213900-24-063627-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.